Keit Men Wong

Dr. Keit Men Wong

Neuropediatrics, Jena University Hospital, Jena, Thuringia, Germany
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2020 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
EBElisabetta Babetto
Elisabetta Babetto
KWKeit Men Wong
Keit Men Wong
Bogdan BeirowskiBogdan Beirowski
Bogdan Beirowski

8 May 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
Bogdan BeirowskiBogdan Beirowski
Bogdan Beirowski
KWKeit Men Wong
Keit Men Wong
EBElisabetta Babetto
Elisabetta Babetto
JMJeffrey Milbrandt
Jeffrey Milbrandt
Significance: The myelination of axons is essential for neuronal wiring and normal nervous system functions. In the peripheral nervous system, Schwann cells (SCs) form myelin sheaths around axons during nerve development. Such myelination is compromised in a number of diseases. Hence, identification and understanding of the key pathways regulating SC development and myelinogenesis are essential for therapeutic progress. Here we uncover two separate roles of the cellular signaling node mTORC1 (mechanistic target of rapamycin complex 1) for regulating the development of SCs and subsequently the growth of myelin sheaths. Moreover, we demonstrate that defective SCs possess a remarkable plasticity to remyelinate axons via mTORC1. Thus, manipulating mTORC1 activity in diseased SCs could be therapeutically beneficial.

1 January 2017 in Neural Regeneration Research
Verified
Journal Article
Open access
PDF file
EBElisabetta Babetto
Elisabetta Babetto
Bogdan BeirowskiBogdan Beirowski
Bogdan Beirowski
KWKeit Men Wong
Keit Men Wong
Axonal degeneration is a pivotal feature of many neurodegenerative conditions and substantially accounts for neurological morbidity. A widely used experimental model to study the mechanisms of axonal degeneration is Wallerian degeneration (WD), which occurs after acute axonal injury. In the peripheral nervous system (PNS), WD is characterized by swift dismantling and clearance of injured axons with their myelin sheaths. This is a prerequisite for successful axonal regeneration. In the central nervous system (CNS), WD is much slower, which significantly contributes to failed axonal regeneration. Although it is well-documented that Schwann cells (SCs) have a critical role in the regenerative potential of the PNS, to date we have only scarce knowledge as to how SCs 'sense' axonal injury and immediately respond to it. In this regard, it remains unknown as to whether SCs play the role of a passive bystander or an active director during the execution of the highly orchestrated disintegration program of axons. Older reports, together with more recent studies, suggest that SCs mount dynamic injury responses minutes after axonal injury, long before axonal breakdown occurs. The swift SC response to axonal injury could play either a pro-degenerative role, or alternatively a supportive role, to the integrity of distressed axons that have not yet committed to degenerate. Indeed, supporting the latter concept, recent findings in a chronic PNS neurodegeneration model indicate that deactivation of a key molecule promoting SC injury responses exacerbates axonal loss. If this holds true in a broader spectrum of conditions, it may provide the grounds for the development of new glia-centric therapeutic approaches to counteract axonal loss.

1 September 2015 in Neuroscience
Verified
Journal Article
Closed access
JBJ.S. Baizer
J.S. Baizer
KWKeit Men Wong
Keit Men Wong
SMS. Manohar
S. Manohar
SHS.H. Hayes
S.H. Hayes
DDD. Ding
D. Ding
RSR.J. Salvi
R.J. Salvi

18 August 2014 in The Anatomical Record
Verified
Journal Article
Open access
PDF file
JBJoan S. Baizer
Joan S. Baizer
KWKeit Men Wong
Keit Men Wong
NPNicholas A. Paolone
Nicholas A. Paolone
NWNadav Weinstock
Nadav Weinstock
RSRichard J. Salvi
Richard J. Salvi
PHPatrick R. Hof
Patrick R. Hof
The dorsal cochlear nucleus (DCN) is a brainstem structure that receives input from the auditory nerve. Many studies in a diversity of species have shown that the DCN has a laminar organization and identifiable neuron types with predictable synaptic relations to each other. In contrast, studies on the human DCN have found a less distinct laminar organization and fewer cell types, although there has been disagreement among studies in how to characterize laminar organization and which of the cell types identified in other animals are also present in humans. We have reexamined DCN organization in the human using immunohistochemistry to analyze the expression of several proteins that have been useful in delineating the neurochemical organization of other brainstem structures in humans: nonphosphorylated neurofilament protein (NPNFP), nitric oxide synthase (nNOS), and three calcium‐binding proteins. The results for humans suggest a laminar organization with only two layers, and the presence of large projection neurons that are enriched in NPNFP. We did not observe evidence in humans of the inhibitory interneurons that have been described in the cat and rodent DCN. To compare humans and other animals directly we used immunohistochemistry to examine the DCN in the macaque monkey, the cat, and three rodents. We found similarities between macaque monkey and human in the expression of NPNFP and nNOS, and unexpected differences among species in the patterns of expression of the calcium‐binding proteins. Anat Rec, 297:1865–1884, 2014.

27 June 2022 in Brain
Verified
Journal Article
Closed access
PDF file
KWKeit Men Wong
Keit Men Wong
WJWayne M Jepsen
Wayne M Jepsen
SEStephanie Efthymiou
Stephanie Efthymiou
VSVincenzo Salpietro
Vincenzo Salpietro
MSMeredith Sanchez-Castillo
Meredith Sanchez-Castillo
PHPeter Huppke
Peter Huppke
TAF8 is part of the transcription factor II D complex, composed of the TATA-binding protein and 13 TATA-binding protein–associated factors (TAFs). Transcription factor II D is the first general transcription factor recruited at promoters to assemble the RNA polymerase II preinitiation complex. So far disorders related to variants in 5 of the 13 subunits of human transcription factor II D have been described. Recently, a child with a homozygous c.781-1G>A mutation in TAF8 has been reported. Here we describe seven further patients with mutations in TAF8 and thereby confirm the TAF8 related disorder. In two sibling patients, we identified two novel compound heterozygous TAF8 splice site mutations, c.45+4A > G and c.489G>A, which cause aberrant splicing as well as reduced expression and mislocalization of TAF8. In five further patients, the previously described c.781-1G > A mutation was present on both alleles. The clinical phenotype associated with the different TAF8 mutations is characterized by severe psychomotor retardation with almost absent development, feeding problems, microcephaly, growth retardation, spasticity and epilepsy. Cerebral imaging showed hypomyelination, a thin corpus callosum and brain atrophy. Moreover, repeated imaging in the sibling pair demonstrated progressive cerebral and cerebellar atrophy. Consistently, reduced N-acetylaspartate, a marker of neuronal viability, was observed on magnetic resonance spectroscopy. Further review of the literature shows that mutations causing a reduced expression of transcription factor II D subunits have an overlapping phenotype of microcephaly, developmental delay and intellectual disability. Although transcription factor II D plays an important role in RNA polymerase II transcription in all cells and tissues, the symptoms associated with such defects are almost exclusively neurological. This might indicate a specific vulnerability of neuronal tissue to widespread deregulation of gene expression as also seen in Rett syndrome or Cornelia de Lange syndrome.